1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing population addicted to smoking
5.1.1.2. Escalating patient safety issues
5.1.2. Restraints
5.1.2.1. Issues related to clinical trials
5.1.3. Opportunities
5.1.3.1. Rising R&D activities
5.1.3.2. Increasing adoption of drug safety facilitating the launch of new drugs
5.1.4. Challenges
5.1.4.1. Adverse effects of drugs
5.2. Cumulative Impact of COVID-19

6. Drug Safety Market, by Functionality
6.1. Introduction
6.2. ADR Reporting
6.3. Drug Safety Audits
6.4. Fully Integrated Software
6.5. Issue Tracking

7. Drug Safety Market, by Delivery Mode
7.1. Introduction
7.2. On-demand
7.3. On-premise

8. Drug Safety Market, by End User
8.1. Introduction
8.2. BPOs
8.3. CROs
8.4. Pharma & biotech companies

9. Americas Drug Safety Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Drug Safety Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Drug Safety Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. AB CUBE
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Accenture, Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Anju Software Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. ArisGlobal LLC(Nordic Capital)
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Cinven
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Cognizant Technology Solutions Corp
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Ergomed PLC
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. EXTEDO GmbH
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Genpact
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. HCL Technologies Limited
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Indigene Pharmaceuticals, Inc.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. IQVIA Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Medco Health Solutions, Inc.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Nordic Capital
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Oracle Corporation
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Parexel International Corporation
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Pharmaceutical Product Development, LLC
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. PRA Health Sciences, Inc.
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Sarjen Systems Pvt. Ltd
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Sparta Systems Inc.
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Syneos Health, Inc.
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Telerx
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Umbra Global LLC
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Worldwide Clinical Trials
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL DRUG SAFETY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL DRUG SAFETY MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL DRUG SAFETY MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL DRUG SAFETY MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL DRUG SAFETY MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL DRUG SAFETY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL DRUG SAFETY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL DRUG SAFETY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL DRUG SAFETY MARKET DYNAMICS
FIGURE 11. GLOBAL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2021 VS 2027 (%)
FIGURE 12. GLOBAL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL DRUG SAFETY MARKET COMPETITIVE STRATEGIC WINDOW, BY FUNCTIONALITY, 2027
FIGURE 14. GLOBAL DRUG SAFETY MARKET SIZE, BY ADR REPORTING, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL DRUG SAFETY MARKET SIZE, BY DRUG SAFETY AUDITS, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL DRUG SAFETY MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL DRUG SAFETY MARKET SIZE, BY ISSUE TRACKING, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2021 VS 2027 (%)
FIGURE 19. GLOBAL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL DRUG SAFETY MARKET COMPETITIVE STRATEGIC WINDOW, BY DELIVERY MODE, 2027
FIGURE 21. GLOBAL DRUG SAFETY MARKET SIZE, BY ON-DEMAND, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL DRUG SAFETY MARKET SIZE, BY ON-PREMISE, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 24. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL DRUG SAFETY MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 26. GLOBAL DRUG SAFETY MARKET SIZE, BY BPOS, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL DRUG SAFETY MARKET SIZE, BY CROS, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL DRUG SAFETY MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2018-2027 (USD MILLION)
FIGURE 29. AMERICAS DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 30. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 31. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 32. AMERICAS DRUG SAFETY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 33. ARGENTINA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. BRAZIL DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. CANADA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. MEXICO DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. UNITED STATES DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 39. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 40. UNITED STATES DRUG SAFETY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 41. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 43. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 44. ASIA-PACIFIC DRUG SAFETY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 45. AUSTRALIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. CHINA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. INDIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. INDONESIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. JAPAN DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. MALAYSIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. PHILIPPINES DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. SINGAPORE DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. SOUTH KOREA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. TAIWAN DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. THAILAND DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. VIETNAM DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 61. DENMARK DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. EGYPT DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. FINLAND DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. FRANCE DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. GERMANY DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. ISRAEL DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. ITALY DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. NETHERLANDS DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. NIGERIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. NORWAY DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. POLAND DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. QATAR DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. RUSSIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. SAUDI ARABIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. SOUTH AFRICA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. SPAIN DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. SWEDEN DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. SWITZERLAND DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. TURKEY DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. UNITED KINGDOM DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. GLOBAL DRUG SAFETY MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 83. GLOBAL DRUG SAFETY MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 84. GLOBAL DRUG SAFETY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021

List of Tables

TABLE 1. GLOBAL DRUG SAFETY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL DRUG SAFETY MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL DRUG SAFETY MARKET SIZE, BY ADR REPORTING, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL DRUG SAFETY MARKET SIZE, BY ADR REPORTING, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL DRUG SAFETY MARKET SIZE, BY ADR REPORTING, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL DRUG SAFETY MARKET SIZE, BY DRUG SAFETY AUDITS, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL DRUG SAFETY MARKET SIZE, BY DRUG SAFETY AUDITS, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL DRUG SAFETY MARKET SIZE, BY DRUG SAFETY AUDITS, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL DRUG SAFETY MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL DRUG SAFETY MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL DRUG SAFETY MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL DRUG SAFETY MARKET SIZE, BY ISSUE TRACKING, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL DRUG SAFETY MARKET SIZE, BY ISSUE TRACKING, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL DRUG SAFETY MARKET SIZE, BY ISSUE TRACKING, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL DRUG SAFETY MARKET SIZE, BY ON-DEMAND, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL DRUG SAFETY MARKET SIZE, BY ON-DEMAND, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL DRUG SAFETY MARKET SIZE, BY ON-DEMAND, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL DRUG SAFETY MARKET SIZE, BY ON-PREMISE, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL DRUG SAFETY MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL DRUG SAFETY MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL DRUG SAFETY MARKET SIZE, BY BPOS, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL DRUG SAFETY MARKET SIZE, BY BPOS, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL DRUG SAFETY MARKET SIZE, BY BPOS, BY REGION, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL DRUG SAFETY MARKET SIZE, BY CROS, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL DRUG SAFETY MARKET SIZE, BY CROS, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL DRUG SAFETY MARKET SIZE, BY CROS, BY REGION, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL DRUG SAFETY MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL DRUG SAFETY MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL DRUG SAFETY MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 36. AMERICAS DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 38. AMERICAS DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 39. AMERICAS DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 40. AMERICAS DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 41. ARGENTINA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. ARGENTINA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 43. ARGENTINA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 44. ARGENTINA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 45. BRAZIL DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. BRAZIL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 47. BRAZIL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 48. BRAZIL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 49. CANADA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 50. CANADA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 51. CANADA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 52. CANADA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 53. MEXICO DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 54. MEXICO DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 55. MEXICO DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 56. MEXICO DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 57. UNITED STATES DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 58. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 59. UNITED STATES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 60. UNITED STATES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 61. UNITED STATES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 62. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 63. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 64. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 65. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 66. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 67. AUSTRALIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 68. AUSTRALIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 69. AUSTRALIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 70. AUSTRALIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 71. CHINA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 72. CHINA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 73. CHINA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 74. CHINA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 75. INDIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 76. INDIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 77. INDIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 78. INDIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 79. INDONESIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 80. INDONESIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 81. INDONESIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 82. INDONESIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 83. JAPAN DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 84. JAPAN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 85. JAPAN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 86. JAPAN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 87. MALAYSIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 88. MALAYSIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 89. MALAYSIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 90. MALAYSIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 91. PHILIPPINES DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 92. PHILIPPINES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 93. PHILIPPINES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 94. PHILIPPINES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 95. SINGAPORE DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 96. SINGAPORE DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 97. SINGAPORE DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 98. SINGAPORE DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 99. SOUTH KOREA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 100. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 101. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 102. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 103. TAIWAN DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 104. TAIWAN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 105. TAIWAN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 106. TAIWAN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 107. THAILAND DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 108. THAILAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 109. THAILAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 110. THAILAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 111. VIETNAM DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 112. VIETNAM DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 113. VIETNAM DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 114. VIETNAM DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 120. DENMARK DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 121. DENMARK DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 122. DENMARK DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 123. DENMARK DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 124. EGYPT DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 125. EGYPT DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 126. EGYPT DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 127. EGYPT DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 128. FINLAND DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 129. FINLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 130. FINLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 131. FINLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 132. FRANCE DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. FRANCE DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 134. FRANCE DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 135. FRANCE DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 136. GERMANY DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 137. GERMANY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 138. GERMANY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 139. GERMANY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 140. ISRAEL DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 141. ISRAEL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 142. ISRAEL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 143. ISRAEL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 144. ITALY DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 145. ITALY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 146. ITALY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 147. ITALY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 148. NETHERLANDS DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 149. NETHERLANDS DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 150. NETHERLANDS DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 151. NETHERLANDS DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 152. NIGERIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 153. NIGERIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 154. NIGERIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 155. NIGERIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 156. NORWAY DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 157. NORWAY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 158. NORWAY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 159. NORWAY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 160. POLAND DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 161. POLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 162. POLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 163. POLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 164. QATAR DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 165. QATAR DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 166. QATAR DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 167. QATAR DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 168. RUSSIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 169. RUSSIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 170. RUSSIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 171. RUSSIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 172. SAUDI ARABIA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 173. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 174. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 175. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 176. SOUTH AFRICA DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 177. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 178. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 179. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 180. SPAIN DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 181. SPAIN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 182. SPAIN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 183. SPAIN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 184. SWEDEN DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 185. SWEDEN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 186. SWEDEN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 187. SWEDEN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 188. SWITZERLAND DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 189. SWITZERLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 190. SWITZERLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 191. SWITZERLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 192. TURKEY DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 193. TURKEY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 194. TURKEY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 195. TURKEY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 200. UNITED KINGDOM DRUG SAFETY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 201. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2027 (USD MILLION)
TABLE 202. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2027 (USD MILLION)
TABLE 203. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 204. GLOBAL DRUG SAFETY MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 205. GLOBAL DRUG SAFETY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 206. GLOBAL DRUG SAFETY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 207. GLOBAL DRUG SAFETY MARKET RANKING, BY KEY PLAYER, 2021
TABLE 208. GLOBAL DRUG SAFETY MARKET SHARE, BY KEY PLAYER, 2021
TABLE 209. GLOBAL DRUG SAFETY MARKET MERGER & ACQUISITION
TABLE 210. GLOBAL DRUG SAFETY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 211. GLOBAL DRUG SAFETY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 212. GLOBAL DRUG SAFETY MARKET INVESTMENT & FUNDING
TABLE 213. GLOBAL DRUG SAFETY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 214. GLOBAL DRUG SAFETY MARKET: LICENSE & PRICING

Companies Mentioned

AB CUBE
Accenture, Inc.
Anju Software Inc.
ArisGlobal LLC(Nordic Capital)
Cinven
Cognizant Technology Solutions Corp
Ergomed PLC
EXTEDO GmbH
Genpact
HCL Technologies Limited
Indigene Pharmaceuticals, Inc.
IQVIA Inc.
Medco Health Solutions, Inc.
Nordic Capital
Oracle Corporation
Parexel International Corporation
Pharmaceutical Product Development, LLC
PRA Health Sciences, Inc.
Sarjen Systems Pvt. Ltd
Sparta Systems Inc.
Syneos Health, Inc.
Telerx
Umbra Global LLC
Worldwide Clinical Trials